Previous close | 1.4000 |
Open | 1.2900 |
Bid | 0.1000 |
Ask | 4.8000 |
Strike | 270.00 |
Expiry date | 2024-06-21 |
Day's range | 1.2800 - 2.6000 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Crispr stock is down for the fifth straight week as the top Cathie Wood's holding struggles amid dim expectations for its gene-editing drug.
In the most recent trading session, Vertex Pharmaceuticals (VRTX) closed at $416.03, indicating a +0.09% shift from the previous trading day.
While CF remains the main area of focus for Vertex Pharmaceuticals (VRTX), it is seeing success in the development of its non-CF pipeline candidates.